Genetic activation of Nrf2 signaling is sufficient to ameliorate neurodegenerative phenotypes in a Drosophila model of Parkinson’s disease
SUMMARY Parkinson’s disease (PD) is the most common neurodegenerative movement disorder. Oxidative stress has been associated with the etiology of both sporadic and monogenic forms of PD. The transcription factor Nrf2, a conserved global regulator of cellular antioxidant responses, has been implicat...
Main Authors: | Maria Cecilia Barone, Gerasimos P. Sykiotis, Dirk Bohmann |
---|---|
Format: | Article |
Language: | English |
Published: |
The Company of Biologists
2011-09-01
|
Series: | Disease Models & Mechanisms |
Online Access: | http://dmm.biologists.org/content/4/5/701 |
Similar Items
-
Keap1/Nrf2 Signaling Pathway
by: Gerasimos P. Sykiotis
Published: (2021-05-01) -
A versatile ΦC31 based reporter system for measuring AP-1 and Nrf2 signaling in Drosophila and in tissue culture.
by: Nirmalya Chatterjee, et al.
Published: (2012-01-01) -
The Keap1/Nrf2 Signaling Pathway in the Thyroid—2020 Update
by: Christina Thanas, et al.
Published: (2020-11-01) -
Keap1/Nrf2 Signaling: A New Player in Thyroid Pathophysiology and Thyroid Cancer
by: Cedric O. Renaud, et al.
Published: (2019-08-01) -
Neurodegenerative models in Drosophila: Polyglutamine disorders, Parkinson disease, and amyotrophic lateral sclerosis
by: Surendra S. Ambegaokar, et al.
Published: (2010-10-01)